Archive · 22 Jul 2026
US Recalls Indian-Made Allergy Tablets Over Contamination
The US has recalled some allergy tablets made in India because they were found to be contaminated with a heartburn drug called ranitidine.
A pharmacy technician noticed some pills had red dots and discoloration, which led to further testing.
Two batches of the tablets failed the tests, and as a precaution, all four batches were recalled.
The affected tablets were shipped between April and June this year.
The recall is to ensure that people don't get sick from taking contaminated medicine.
US recalls Indian-made Cetirizine tablets due to contamination with ranitidine.
A pharmacy technician noticed red dots and discoloration on some pills, triggering an internal investigation.
Batches GY825029, GY825030, GY825031, and GY825032 were tested, with two failing lab checks.
Contamination was traced to ranitidine using LCMS testing.
All four batches were recalled as a precaution, even though only two technically failed.
- Who
- US regulatory authorities and an unnamed pharmacy technician
- What
- Recall of Indian-made Cetirizine tablets due to contamination with ranitidine
- When
- Between April and June 2023
- Where
- United States
- Why
- Contamination with ranitidine and degradation products beyond acceptable limits
Pharmaceutical Safety Advocates
Manufacturers and Distributors
Recall Necessity
Pharmaceutical Safety Advocates
The recall is crucial to prevent potential health risks from contaminated medication.
Manufacturers and Distributors
The recall may be overly cautious, impacting supply and causing unnecessary alarm.
- Product
- Cetirizine tablets
- Contaminant
- Ranitidine
- Affected Batches
- GY825029, GY825030, GY825031, GY825032
- Recall Period
- April to June 2023
- Testing Method
- LCMS (Liquid Chromatography-Mass Spectrometry)